These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 15140328

  • 21. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes.
    Puig JG, Marre M, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion D, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Gallois Y, Amouyel P, Ollivier JP, Asmar R.
    Am J Hypertens; 2007 Jan; 20(1):90-7. PubMed ID: 17198918
    [Abstract] [Full Text] [Related]

  • 23. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Jan; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 24. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Paoletti E, Cassottana P, Amidone M, Gherzi M, Rolla D, Cannella G.
    Am J Kidney Dis; 2007 Jul; 50(1):133-42. PubMed ID: 17591533
    [Abstract] [Full Text] [Related]

  • 25. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C.
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [Abstract] [Full Text] [Related]

  • 26. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E.
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [Abstract] [Full Text] [Related]

  • 27. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P, Angeli F, Gattobigio R, Guerrieri M, Benemio G, Porcellati C.
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [Abstract] [Full Text] [Related]

  • 28. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O, Inal V, Baysan O, Sağlam K.
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
    [Abstract] [Full Text] [Related]

  • 29. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G.
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
    [Abstract] [Full Text] [Related]

  • 30. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL, Robinson H, Brown R, Olivan J, Sami M, Honos G, Ruddy TD, Balazovjech I, Touzek F, Galinier F, Mariani M, de Cordoüe A, Barrandon S, Brault Y, Guez D.
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [Abstract] [Full Text] [Related]

  • 31. [Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study].
    Li Y, Zhao D, Liu J, Li CF, Guo W, Chen CH, Hao P, Sun JY, Qin LP, Wang W.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1037-42. PubMed ID: 19102921
    [Abstract] [Full Text] [Related]

  • 32. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
    Cuspidi C, Negri F, Giudici V, Valerio C, Meani S, Sala C, Esposito A, Masaidi M, Zanchetti A, Mancia G.
    J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
    Gosse P, Dubourg O, Guéret P, De Simone G, Schmieder R, De Leeuw PW, Degaute JP, García Puig J, Karpov Y, Magometschnigg D, Matos L, Amouyel P, Asmar R, Le Heuzey JY, Nieminen M, Dahlöf B.
    J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
    [Abstract] [Full Text] [Related]

  • 34. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
    Cardio-Sis Study Group.
    J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
    [Abstract] [Full Text] [Related]

  • 35. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
    Almeida P, Azevedo A, Rodrigues R, Dias P, Friões F, Vazquez B, Abreu-Lima C, Bettencourt P, Barros H.
    Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
    [Abstract] [Full Text] [Related]

  • 36. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
    Donnelly R.
    Clin Pharmacokinet; 1999 Mar; 37 Suppl 1():21-32. PubMed ID: 10491730
    [Abstract] [Full Text] [Related]

  • 37. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension].
    Asmar R.
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936
    [Abstract] [Full Text] [Related]

  • 38. Regression of left ventricular hypertrophy: do antihypertensive classes differ?
    Sheridan DJ.
    J Hypertens Suppl; 2000 Jul; 18(3):S21-7. PubMed ID: 10952084
    [Abstract] [Full Text] [Related]

  • 39. Effects of antihypertensive therapy on left ventricular hypertrophy of essential hypertension: a role for insulin-like growth factor I?
    Díez J, Laviades C, Mayor G.
    J Hum Hypertens; 1993 Oct; 7(5):479-84. PubMed ID: 8263889
    [Abstract] [Full Text] [Related]

  • 40. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG, Devereux RB.
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.